Jeffrey W. Albers

Director

Director at Spyre Therapeutics, Inc., filing insider transactions on 2026-08-07.

Total Purchases

—

0 transactions

Total Sales

$2.4M

3 transactions

Companies Traded

1

3 total filings

Active Since

2026-08-07

Last: 2026-08-07

Companies

Spyre Therapeutics, Inc.

Other Reporting Insiders at Spyre Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-07	SYRE	Sale	10.0K	$104.68	$1.0M	9,360	SEC ↗
2026-08-07	SYRE	Sale	5,000	$104.47	$522K	0	SEC ↗
2026-08-07	SYRE	Sale	8,000	$104.38	$835K	19.4K

Jeffrey W. Albers (Spyre Therapeutics, Inc.) Insider Trades | Tormere